PMC:7033698 / 8965-9181 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T75","span":{"begin":113,"end":116},"obj":"Body_part"}],"attributes":[{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"We do not see any selection benefit or rationale for 2019-nCoV to obtain and mix structurally unrelated parts of HIV-1 to generate a unique structure for its enhanced receptor binding as indicated by the authors [8]."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T83","span":{"begin":131,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We do not see any selection benefit or rationale for 2019-nCoV to obtain and mix structurally unrelated parts of HIV-1 to generate a unique structure for its enhanced receptor binding as indicated by the authors [8]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T75","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We do not see any selection benefit or rationale for 2019-nCoV to obtain and mix structurally unrelated parts of HIV-1 to generate a unique structure for its enhanced receptor binding as indicated by the authors [8]."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"251","span":{"begin":53,"end":62},"obj":"Species"},{"id":"252","span":{"begin":113,"end":118},"obj":"Species"}],"attributes":[{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"Tax:2697049"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"Tax:11676"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We do not see any selection benefit or rationale for 2019-nCoV to obtain and mix structurally unrelated parts of HIV-1 to generate a unique structure for its enhanced receptor binding as indicated by the authors [8]."}